Safety Information

Description Publish Date LINKS
Important safety information for HCPs in Malawi: Notification about recall 04/10/2021
Important safety information on Abacavir: Hypersensitivity reaction - educational slide deck 15/02/2024

Important safety information on Cephalosporins in Malawi (Safety Notification_Cephalosporins and risk of neurotoxicity)

07/03/2023

Important safety information on Amoxicillin / Amoxicillin and clavulanic acid containing products in Malawi

09/09/2023
Important safety information on Dolutegravir containing products in Malawi (Safety Notification_Korean label update for Dolutegravir containing products) 02-11-2023

Important safety information on Amoxicillin/clavulanic acid containing products - MedSafe communication regarding labelling updates

19/12/2023

Important safety information on Zanamivir containing products - Precautions for prescribing and administering flu medications (zanamivir)

26/12/2023

This site is intended only for healthcare professionals. By clicking the button “I am a healthcare professional” you confirm that you are a member of the medical/dental/pharmacy/nursing professions and/or you are any other person who, in the course of the employment and delivery of patient care, may prescribe, recommend, purchase, administer, supply (or influence the supply) of medicines.

I am a healthcare professional

This site is intended for members of the public, patients and their carers.

 

 

 

 

 

I am a member of the public